Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Goodwill (2016 - 2025)

Standard Biotools (LAB) has disclosed Goodwill for 12 consecutive years, with $111.7 million as the latest value for Q1 2025.

  • On a quarterly basis, Goodwill rose 5.13% to $111.7 million in Q1 2025 year-over-year; TTM through Mar 2025 was $111.7 million, a 5.13% increase, with the full-year FY2024 number at $111.3 million, up 4.68% from a year prior.
  • Goodwill was $111.7 million for Q1 2025 at Standard Biotools, roughly flat from $111.3 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $111.7 million in Q1 2025 to a low of $106.2 million in Q3 2023.
  • A 5-year average of $107.3 million and a median of $106.3 million in 2023 define the central range for Goodwill.
  • Peak YoY movement for Goodwill: fell 0.12% in 2022, then grew 5.13% in 2025.
  • Standard Biotools' Goodwill stood at $106.4 million in 2021, then dropped by 0.12% to $106.3 million in 2022, then grew by 0.06% to $106.3 million in 2023, then increased by 4.68% to $111.3 million in 2024, then increased by 0.38% to $111.7 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Goodwill are $111.7 million (Q1 2025), $111.3 million (Q4 2024), and $106.3 million (Q3 2024).